Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 18 2024
0mins
Should l Buy ?
Source: Businesswire
Jury Verdict: Axonics, Inc. won a unanimous jury verdict in a patent infringement lawsuit against Medtronic, confirming that Axonics does not infringe on the patents in question.
Company Overview: Axonics is recognized for its innovative medical technology aimed at treating bladder and bowel dysfunction, ranking as one of the fastest-growing companies in the Americas.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
